Correlation Between Cybin and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cybin and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cybin and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cybin Inc and Mydecine Innovations Group, you can compare the effects of market volatilities on Cybin and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cybin with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cybin and Mydecine Innovations.

Diversification Opportunities for Cybin and Mydecine Innovations

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Cybin and Mydecine is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Cybin Inc and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Cybin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cybin Inc are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Cybin i.e., Cybin and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Cybin and Mydecine Innovations

Given the investment horizon of 90 days Cybin is expected to generate 3012.5 times less return on investment than Mydecine Innovations. But when comparing it to its historical volatility, Cybin Inc is 11.28 times less risky than Mydecine Innovations. It trades about 0.0 of its potential returns per unit of risk. Mydecine Innovations Group is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  41.00  in Mydecine Innovations Group on October 29, 2024 and sell it today you would lose (40.60) from holding Mydecine Innovations Group or give up 99.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cybin Inc  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Cybin Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cybin Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Cybin is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Mydecine Innovations 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Cybin and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cybin and Mydecine Innovations

The main advantage of trading using opposite Cybin and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cybin position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Cybin Inc and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios